Skanska to build biotech plant for Pfizer for SEK 600 M
Skanska has been commissioned to build a biotech plant in Strängnäs, Sweden. Skanska will also be responsible for installing the process equipment. Skanska’s contract amounts to approximately SEK 600 M, which will be included in order bookings for the fourth quarter. Of the amount, 60 percent is included in Skanska Sweden and 40 percent in Skanska USA Building.